Sino Biopharmaceutical Ltd. (SBHMY)
Sino Biopharmaceutical Market Cap: 16.30B for Jan. 9, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| HUTCHMED (China) Ltd. | 2.530B |
| Regencell Bioscience Holdings Ltd. | 22.64B |
| Prenetics Global Ltd. | 261.35M |
| Cellyan Biotechnology Ltd. | 8.526M |
| Charming Medical Ltd. | 504.26M |
Market Cap Related Metrics
| PS Ratio | 3.869 |
| PEG Ratio | 0.3302 |
| Price to Book Value | 4.286 |
| Price to Free Cash Flow | 14.88 |
| Price | 18.22 |
| Earnings Yield | 3.14% |
| PEGY Ratio | 0.3259 |
| Operating PE Ratio | 18.58 |
| Normalized PE Ratio | 28.04 |